253 related articles for article (PubMed ID: 31563608)
21. Association of LOXL1 gene with Finnish exfoliation syndrome patients.
Lemmelä S; Forsman E; Onkamo P; Nurmi H; Laivuori H; Kivelä T; Puska P; Heger M; Eriksson A; Forsius H; Järvelä I
J Hum Genet; 2009 May; 54(5):289-97. PubMed ID: 19343041
[TBL] [Abstract][Full Text] [Related]
22. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
23. Integral role for lysyl oxidase-like-1 in conventional outflow tissue function and behavior.
Li G; Schmitt H; Johnson WM; Lee C; Navarro I; Cui J; Fleming T; Gomez-Caraballo M; Elliott MH; Sherwood JM; Hauser MA; Farsiu S; Ethier CR; Stamer WD
FASEB J; 2020 Aug; 34(8):10762-10777. PubMed ID: 32623782
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.
Chen L; Jia L; Wang N; Tang G; Zhang C; Fan S; Liu W; Meng H; Zeng W; Liu N; Wang H; Jia H
Mol Vis; 2009 Nov; 15():2349-57. PubMed ID: 19936304
[TBL] [Abstract][Full Text] [Related]
25. Association of Lysyl Oxidase-Like 1 Gene Polymorphisms in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma in a Spanish Population.
de Juan-Marcos L; Escudero-Domínguez FA; Hernández-Galilea E; Cabrillo-Estévez L; Cruz-González F; Cieza-Borrella C; Sánchez-Barba M; González-Sarmiento R
Ophthalmic Genet; 2016; 37(1):25-30. PubMed ID: 24892565
[TBL] [Abstract][Full Text] [Related]
26. Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.
Mossböck G; Renner W; Faschinger C; Schmut O; Wedrich A; Weger M
Mol Vis; 2008 May; 14():857-61. PubMed ID: 18483563
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
28. Association of LOXL1 gene polymorphisms with exfoliation syndrome/glaucoma and primary open angle glaucoma in a Turkish population.
Kasım B; İrkeç M; Alikaşifoğlu M; Orhan M; Mocan MC; Aktaş D
Mol Vis; 2013; 19():114-20. PubMed ID: 23378724
[TBL] [Abstract][Full Text] [Related]
29. Ethnicity-based subgroup meta-analysis of the association of LOXL1 polymorphisms with glaucoma.
Chen H; Chen LJ; Zhang M; Gong W; Tam PO; Lam DS; Pang CP
Mol Vis; 2010 Feb; 16():167-77. PubMed ID: 20142848
[TBL] [Abstract][Full Text] [Related]
30. Exfoliation syndrome and exfoliation glaucoma-associated LOXL1 variations are not involved in pigment dispersion syndrome and pigmentary glaucoma.
Rao KN; Ritch R; Dorairaj SK; Kaur I; Liebmann JM; Thomas R; Chakrabarti S
Mol Vis; 2008 Jul; 14():1254-62. PubMed ID: 18618003
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in the Uygur population.
Mayinu ; Chen X
Mol Vis; 2011; 17():1734-44. PubMed ID: 21738402
[TBL] [Abstract][Full Text] [Related]
32. The association of LOXL1 polymorphisms with exfoliation syndrome/glaucoma: Meta-analysis.
Ji QS; Qi B; Wen YC; Liu L; Guo XL; Yu GC; Zhong JX
Int J Ophthalmol; 2015; 8(1):148-56. PubMed ID: 25709925
[TBL] [Abstract][Full Text] [Related]
33. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.
Mori K; Imai K; Matsuda A; Ikeda Y; Naruse S; Hitora-Takeshita H; Nakano M; Taniguchi T; Omi N; Tashiro K; Kinoshita S
Mol Vis; 2008 Jun; 14():1037-40. PubMed ID: 18552979
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Matrix Regulation and Dysregulation in Exfoliation Syndrome.
Zenkel M
J Glaucoma; 2018 Jul; 27 Suppl 1():S24-S28. PubMed ID: 29432335
[TBL] [Abstract][Full Text] [Related]
35. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
36. Novel common variants and susceptible haplotype for exfoliation glaucoma specific to Asian population.
Nakano M; Ikeda Y; Tokuda Y; Fuwa M; Ueno M; Imai K; Sato R; Omi N; Adachi H; Kageyama M; Mori K; Kinoshita S; Tashiro K
Sci Rep; 2014 Jun; 4():5340. PubMed ID: 24938310
[TBL] [Abstract][Full Text] [Related]
37. Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort.
Yang X; Zabriskie NA; Hau VS; Chen H; Tong Z; Gibbs D; Farhi P; Katz BJ; Luo L; Pearson E; Goldsmith J; Ma X; Kaminoh Y; Chen Y; Yu B; Zeng J; Zhang K; Yang Z
Cell Cycle; 2008 Feb; 7(4):521-4. PubMed ID: 18287813
[TBL] [Abstract][Full Text] [Related]
38. Major review: Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology.
Aboobakar IF; Johnson WM; Stamer WD; Hauser MA; Allingham RR
Exp Eye Res; 2017 Jan; 154():88-103. PubMed ID: 27845061
[TBL] [Abstract][Full Text] [Related]
39. Review: The role of LOXL1 in exfoliation syndrome/glaucoma.
Whigham BT; Allingham RR
Saudi J Ophthalmol; 2011 Oct; 25(4):347-52. PubMed ID: 23960948
[TBL] [Abstract][Full Text] [Related]
40. Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population.
Hayashi H; Gotoh N; Ueda Y; Nakanishi H; Yoshimura N
Am J Ophthalmol; 2008 Mar; 145(3):582-585. PubMed ID: 18201684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
